PortfoliosLab logoPortfoliosLab logo
CAPR vs. QVCGA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CAPR vs. QVCGA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Capricor Therapeutics, Inc. (CAPR) and QVC Group Inc (QVCGA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


CAPR

1D
3.38%
1M
1.63%
YTD
1.66%
6M
-0.54%
1Y
255.21%
3Y*
79.77%
5Y*
41.24%
10Y*
-3.48%

QVCGA

1D
0.00%
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CAPR vs. QVCGA - Yearly Performance Comparison


2026 (YTD)
CAPR
Capricor Therapeutics, Inc.
0.69%
QVCGA
QVC Group Inc
0.00%

Fundamentals

Market Cap

CAPR:

$1.69B

QVCGA:

$2.75M

EPS

CAPR:

-$2.32

QVCGA:

-$302.09

Total Revenue (TTM)

CAPR:

$0.00

QVCGA:

$9.23B

Gross Profit (TTM)

CAPR:

-$42.41M

QVCGA:

$2.89B

EBITDA (TTM)

CAPR:

-$117.24M

QVCGA:

$789.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CAPR vs. QVCGA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CAPR
CAPR Risk / Return Rank: 8787
Overall Rank
CAPR Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
CAPR Sortino Ratio Rank: 9999
Sortino Ratio Rank
CAPR Omega Ratio Rank: 9898
Omega Ratio Rank
CAPR Calmar Ratio Rank: 9090
Calmar Ratio Rank
CAPR Martin Ratio Rank: 8686
Martin Ratio Rank

QVCGA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CAPR vs. QVCGA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Capricor Therapeutics, Inc. (CAPR) and QVC Group Inc (QVCGA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CAPRQVCGADifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.77

Calmar ratioReturn relative to maximum drawdown

4.30

Martin ratioReturn relative to average drawdown

8.90

CAPR vs. QVCGA - Sharpe Ratio Comparison


Loading charts...

Drawdowns

CAPR vs. QVCGA - Drawdown Comparison

The maximum CAPR drawdown since its inception was -99.97%, which is greater than QVCGA's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for CAPR and QVCGA.


Loading charts...

Drawdown Indicators


CAPRQVCGADifference

Max Drawdown

Largest peak-to-trough decline

-99.97%

0.00%

-99.97%

Max Drawdown (1Y)

Largest decline over 1 year

-59.72%

Max Drawdown (3Y)

Largest decline over 3 years

-79.08%

Max Drawdown (5Y)

Largest decline over 5 years

-79.08%

Max Drawdown (10Y)

Largest decline over 10 years

-97.83%

Current Drawdown

Current decline from peak

-99.10%

0.00%

-99.10%

Average Drawdown

Average peak-to-trough decline

-90.25%

0.00%

-90.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.82%

Volatility

CAPR vs. QVCGA - Volatility Comparison


Loading charts...

Volatility by Period


CAPRQVCGADifference

Volatility (1M)

Calculated over the trailing 1-month period

14.13%

Volatility (6M)

Calculated over the trailing 6-month period

49.34%

Volatility (1Y)

Calculated over the trailing 1-year period

383.51%

0.00%

+383.51%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

190.03%

0.00%

+190.03%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

179.74%

0.00%

+179.74%

Dividends

CAPR vs. QVCGA - Dividend Comparison

Neither CAPR nor QVCGA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CAPR vs. QVCGA - Financials Comparison

This section allows you to compare key financial metrics between Capricor Therapeutics, Inc. and QVC Group Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B202220232024202520260
2.68B
(CAPR) Total Revenue
(QVCGA) Total Revenue
Values in USD except per share items
Portfolio Optimizer

Find the right allocation for CAPR and QVCGA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer